These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15603969)

  • 21. Design and synthesis of 1,3-diarylurea derivatives as selective cyclooxygenase (COX-2) inhibitors.
    Zarghi A; Kakhgi S; Hadipoor A; Daraee B; Dadrass OG; Hedayati M
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1336-9. PubMed ID: 18226898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of acyclic triaryl (Z)-olefins possessing a 3,5-di-tert-butyl-4-hydroxyphenyl pharmacophore: dual inhibitors of cyclooxygenases and lipoxygenases.
    Moreau A; Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Aug; 14(15):5340-50. PubMed ID: 16677817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and cyclooxygenase-2 inhibiting property of 1,5-diarylpyrazoles with substituted benzenesulfonamide moiety as pharmacophore: Preparation of sodium salt for injectable formulation.
    Pal M; Madan M; Padakanti S; Pattabiraman VR; Kalleda S; Vanguri A; Mullangi R; Mamidi NV; Casturi SR; Malde A; Gopalakrishnan B; Yeleswarapu KR
    J Med Chem; 2003 Sep; 46(19):3975-84. PubMed ID: 12954051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and biological evaluation of 1,3-diarylprop-2-en-1-ones : a novel class of cyclooxygenase-2 inhibitors.
    Zarghi A; Arfaee S; Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Apr; 14(8):2600-5. PubMed ID: 16356730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro structure-activity relationship and in vivo studies for a novel class of cyclooxygenase-2 inhibitors: 5-aryl-2,2-dialkyl-4-phenyl-3(2H)furanone derivatives.
    Shin SS; Byun Y; Lim KM; Choi JK; Lee KW; Moh JH; Kim JK; Jeong YS; Kim JY; Choi YH; Koh HJ; Park YH; Oh YI; Noh MS; Chung S
    J Med Chem; 2004 Feb; 47(4):792-804. PubMed ID: 14761182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological activity of disubstituted 4,5-polymethylenepyrazoles as selective cyclooxygenase-2 inhibitors.
    Yu JW; Kim HH; Jahng Y
    Pharmazie; 2002 May; 57(5):301-5. PubMed ID: 12061251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and biological evaluation of (E)- and (Z)-styryl-2-acetoxyphenyl sulfides and sulfones as cyclooxygenase-2 inhibitors.
    Reddy MV; Mallireddigari MR; Pallela VR; Venkatapuram P; Boominathan R; Bell SC; Reddy EP
    Bioorg Med Chem; 2005 Mar; 13(5):1715-23. PubMed ID: 15698789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, biological activity and molecular modeling studies of novel COX-1 inhibitors.
    Martić M; Tatić I; Marković S; Kujundzić N; Kostrun S
    Eur J Med Chem; 2004 Feb; 39(2):141-51. PubMed ID: 14987823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of 4,5-diaryl-1H-pyrazole-3-ol derivatives as potential COX-2 inhibitors.
    Patel MV; Bell R; Majest S; Henry R; Kolasa T
    J Org Chem; 2004 Oct; 69(21):7058-65. PubMed ID: 15471453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1,5-Diarylpyrrole-3-acetic acids and esters as novel classes of potent and highly selective cyclooxygenase-2 inhibitors.
    Biava M; Porretta GC; Cappelli A; Vomero S; Manetti F; Botta M; Sautebin L; Rossi A; Makovec F; Anzini M
    J Med Chem; 2005 May; 48(9):3428-32. PubMed ID: 15857149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and selective cyclooxygenase-2 inhibitory activity of a series of novel, nitric oxide donor-containing pyrazoles.
    Ranatunge RR; Augustyniak M; Bandarage UK; Earl RA; Ellis JL; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Schroeder JD; Shumway MJ; Tam SW; Trocha AM; Young DV
    J Med Chem; 2004 Apr; 47(9):2180-93. PubMed ID: 15084117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship.
    Murias M; Handler N; Erker T; Pleban K; Ecker G; Saiko P; Szekeres T; Jäger W
    Bioorg Med Chem; 2004 Nov; 12(21):5571-8. PubMed ID: 15465334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclooxygenase-1 and cyclooxygenase-2 inhibition of novel 1,2-disubstituted imidazoles.
    Handler N; Jaeger W; Kuen-Krismer B; Erker T
    Arch Pharm (Weinheim); 2005 Dec; 338(12):602-4. PubMed ID: 16353278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomide.
    Sano H; Noguchi T; Tanatani A; Hashimoto Y; Miyachi H
    Bioorg Med Chem; 2005 May; 13(9):3079-91. PubMed ID: 15809144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of linear phenylethynylbenzenesulfonamide regioisomers as cyclooxygenase-1/-2 (COX-1/-2) inhibitors.
    Anana R; Rao PN; Chen QH; Knaus EE
    Bioorg Med Chem; 2006 Aug; 14(15):5259-65. PubMed ID: 16635574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and biological evaluation of (E)-3-(4-methanesulfonylphenyl)-2-(aryl)acrylic acids as dual inhibitors of cyclooxygenases and lipoxygenases.
    Moreau A; Chen QH; Praveen Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Dec; 14(23):7716-27. PubMed ID: 16931030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of cyclooxygenase-2 (COX-2) inhibitors on prostate cancer cell proliferation.
    Srinath P; Rao PN; Knaus EE; Suresh MR
    Anticancer Res; 2003; 23(5A):3923-8. PubMed ID: 14666698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and structure-activity relationship studies of 3,4,6-triphenylpyran-2-ones as selective cyclooxygenase-2 inhibitors.
    Rao PN; Uddin MJ; Knaus EE
    J Med Chem; 2004 Jul; 47(16):3972-90. PubMed ID: 15267236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigations of new pyridazinone derivatives for the synthesis of potent analgesic and anti-inflammatory compounds with cyclooxygenase inhibitory activity.
    Okçelik B; Unlü S; Banoglu E; Küpeli E; Yeşilada E; Sahin MF
    Arch Pharm (Weinheim); 2003 Sep; 336(9):406-12. PubMed ID: 14528488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Designing selective COX-2 inhibitors: molecular modeling approaches.
    Trummlitz G; van Ryn J
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):550-61. PubMed ID: 12197313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.